Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.VRML · Entity 7871 | Chief Operating Officer | April 13, 2018 | April 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date April 13, 2018 · Filed April 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.89 · Expires 2026-11-08 | Direct | 15,000 |
Reported balance
After 2018-04-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-13 · Grant · Acquired 15,000 · Balance 15,000 F1: An option to purchase 60,000 shares of common stock was granted to the reporting person on 11/8/16, subject to the satisfaction of certain performance conditions. On 4/13/18, a portion of the performance conditions were deemed to have been met, resulting in 15,000 shares earned. The remaining option to purchase 45,000 shares was canceled. Half of the achieved portion of the option grant is immediately exercisable and the remaining 50% will vest on 12/31/18. |
Filing footnotes · ownership attribution and instrument terms
F1: An option to purchase 60,000 shares of common stock was granted to the reporting person on 11/8/16, subject to the satisfaction of certain performance conditions. On 4/13/18, a portion of the performance conditions were deemed to have been met, resulting in 15,000 shares earned. The remaining option to purchase 45,000 shares was canceled. Half of the achieved portion of the option grant is immediately exercisable and the remaining 50% will vest on 12/31/18.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2018 Filed Apr 17, 2018 20:59 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001637904-18-000002 · primary_doc.xml · derivative · entry 1 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-11-08 F1 · derivative.exercise_date: An option to purchase 60,000 shares of common stock was granted to the reporting person on 11/8/16, subject to the satisfaction of certain performance conditions. On 4/13/18, a portion of the performance conditions were deemed to have been met, resulting in 15,000 shares earned. The remaining option to purchase 45,000 shares was canceled. Half of the achieved portion of the option grant is immediately exercisable and the remaining 50% will vest on 12/31/18. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:54 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001637904-18-000001 · primary_doc.xml · derivative · entry 1 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-04-13 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on April 13, 2019. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 21:15 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001637904-17-000002 · primary_doc.xml · derivative · entry 1 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 23, 2018. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:50 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseWarrants (Right to buy) · Derivative | 5,021 | $0.13 Strike: $1.80 | $627.63 |
DisclosureSEC source: 0001637904-17-000001 · primary_doc.xml · derivative · entry 2 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021 Underlying: Common Stock · 5,021 shares Expires 2022-02-17 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:50 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 6,695 | $1.40 | $9,373.00 |
DisclosureSEC source: 0001637904-17-000001 · primary_doc.xml · nonDerivative · entry 1 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,695 Read SEC document |
| November 02, 2016 Filed Nov 3, 2016 20:21 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001637904-16-000007 · primary_doc.xml · derivative · entry 1 FERRARA FRED · CIK 0001637904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-11-02 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on November 1, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.